FDA Peptide Reclassification 2026 Amanecia Health FDA Approves Oral Semaglutide as the First Oral GLP 1 Pill FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin